CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer

Journal of Applied Clinical Medical Physics

Volumn 14, Issue 5, 2013, Pages 153-161

  Jin, Xiance ^a   Yi, Jinling ^a   Zhou, Yongqiang ^a   Yan, Huawei ^a   Han, Ce ^a   Xiea, Congying ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Boost phase; Conformal radiotherapy; Upper thoracic esophageal cancer; Volumetric modulated arc therapy

Indexed keywords

ARTICLE; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; ESOPHAGUS TUMOR; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PATHOLOGY; RADIATION DOSE; RETROSPECTIVE STUDY; THORAX TUMOR;

ESOPHAGEAL NEOPLASMS; HUMANS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; THORACIC NEOPLASMS;

EID: 84884135543     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v14i5.4325     Document Type: Article

References (22)

1. Bradley JD and Muti S. Carcinoma of the esophagus. In: Levitt SH, Purdy JA, Perez CA, Vijayakumar S, editors. Technical basis of radiation therapy: practical clinical applications, 4th revised edition. Berlin: Springer; 2008: p.511-24.
2. Fenkell L, Kaminsky I, Breen S, Huang S, Prooijen MV, Ringash J. Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol. 2008;89(3):287-91.
3. Palta JR, Deye JA, Ibbott GS, Purdy JA, Urie M. Credentialing of institutions for IMRT in the clinical trials. Int J Radiat Oncol Biol Phys. 2004;59(4):1257-59.
4. Advanced Technology Consortium. NCI guidelines on the use of IMRT in clinical trials. Accessed January 2007. Available from: http://atc.wustl.edu/home/NCI/NCI_IMRT_Guidelines.html
5. Mayo CS, Urie MM, Fitzgerald TJ, Ding L, Lo YC, Bogdanov M. Hybrid IMRT for treatment of cancers of the lung and esophagus. Int J Radiat Oncol Biol Phys. 2008;71(5):1408-18.
6. Bertelsen A, Hansen CR, Johansen J, Brink C. Single arc volumetric modulated arc therapy of head and neck cancer. Radiother Oncol. 2010;95(2):142-48.
7. Shaffer R, Morris WJ, Moiseenko V, et al. Volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: a planning comparison study. Clin Oncol. 2009;21(5):401-07.
8. Wolff D, Stierler F, Welzel G, et al. Volumetric intensity modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol. 2009;93(2):226-33.
9. Vivekanandan N, Sriram P, Kumar S, Bhuvaneswari N, and Saranya K
10. Van Benthuysen L, Hales L, Podgorsak MB. Volumetric modulated arc therapy vs. IMRT for the treatment of distal esophageal cancer. Med Dosim. 2011;36(4):404-09.
11. Radiation Therapy Oncology Group. RTOG 0436 A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer who are treated without surgery. Version date: 05/03/2012. Available from: http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0436
12. Wambersie A and Landber T. ICRU Report 62: Prescribing, recording, and reporting photon beam therapy. (Supplement to ICRU Report 50). Bethesda: ICRU; 1999.
13. Lomax NJ and Scheib SG. Quantifying the degree of conformity in radiosurgery treatment planning. Int J Radiat Oncol Biol Phys. 2003;55(5):1409-19.
14. van't Riet A, Mak AC, Moerland MA, Elders LH, van der Zee W. A conformation number to quantify the degree of conformity in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys. 1997;37(3):731-36.
15. Niemierko A and Goiten M. Modeling of normal tissue response to radiation: the critical volume model. Int J Radiat Oncol Biol Phys. 1993;25(1):135-45.
16. Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys. 1995;32(4):1227-37.
17. Hawkins MA, Bedford JL, Warrington AP, Tait DM. Volumetric modulated arc therapy planning for distal oesophageal malignancies. Br J Radiol. 2012;85(1009):44-52.
18. Kwa SL, Lebesque JV, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 1998;42(1):1-9.
19. Wang SL, Liao Z, Vaporciyan AA, et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys. 2006;64(3):692-99.
20. Lee HK, Vaporciyan AA, Cox JD, et al. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys. 2003;57(5):1317-22.
21. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45(2):323-29.
22. Chapet O, Fraass BA, Ten Haken RK. Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors. Int J Radiat Oncol Biol Phys. 2006;65(1):255-65.